| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Peter Sulick CEO | OTC PINK Exchange | 268102209 CUSIP |
| US Country | 207 Employees | 15 Mar 2024 Last Dividend | 1 Nov 1996 Last Split | - IPO Date |
Dynasil Corporation of America is a pioneering company that specializes in the development, marketing, manufacturing, and sale of sophisticated detection, sensing, and analysis technology along with high-quality optical components. With a global footprint that extends across the United States, Asia, Europe, and other international markets, Dynasil has established itself as a leader in its field. Founded in 1960 and based in Newton, Massachusetts, the company operates through three main segments: Optics, Innovation and Development, and Biomedical. Each segment caters to a unique set of applications and industries, ranging from medical and industrial to homeland security/defense. Through its integrated approach that combines direct sales, marketing staff, and strategic partnerships with manufacturer’s representatives and distributors, Dynasil ensures its cutting-edge products and technologies reach a wide array of sectors worldwide.
This division of Dynasil supplies synthetic crystals, optical materials, components, and coatings crucial for a variety of devices. The applications for these products span a wide range of sectors such as medical imaging systems, baggage scanners, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays. These products find their utility in critical areas including the medical sector, industrial applications, and homeland security/defense initiatives.
Dedicated to the advancement of technology, this segment works on the development of new materials, sensors, and prototype instruments that are capable of detecting or measuring various phenomena such as radiation, light, magnetism, or sound. The technologies developed in this segment find applications in security, medical, and industrial domains, showcasing Dynasil's commitment to innovation and the betterment of these critical sectors.
This segment focuses on the biomedical sphere, specifically on the development of tissue sealant products. Through its innovations in the biomedical segment, Dynasil aims to contribute to the health sector by offering advanced solutions that aid in medical procedures and healing processes, highlighting the company's diverse expertise and its contribution to medical advancements.